Literature DB >> 21685754

Salvaging the septic heart through targeting the interleukin-6/p38 mitogen-activated protein kinase signaling network.

Ian G Cannell, Michael B Yaffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21685754      PMCID： PMC3677698          DOI： 10.1097/CCM.0b013e3182204ad1

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  15 in total

Review 1.  Mitogen-activated protein kinases in apoptosis regulation.

Authors:  Teiji Wada; Josef M Penninger
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

Review 2.  MAPKAP kinases - MKs - two's company, three's a crowd.

Authors:  Matthias Gaestel
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

3.  p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.

Authors:  H Christian Reinhardt; Aaron S Aslanian; Jacqueline A Lees; Michael B Yaffe
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

4.  MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels.

Authors:  Armin Neininger; Dimitris Kontoyiannis; Alexey Kotlyarov; Reinhard Winzen; Rolf Eckert; Hans-Dieter Volk; Helmut Holtmann; George Kollias; Matthias Gaestel
Journal:  J Biol Chem       Date:  2001-12-06       Impact factor: 5.157

5.  The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study.

Authors:  Jayaprakash Karkera; Hannes Steiner; Weimin Li; Viktor Skradski; Patrizia L Moser; Sabine Riethdorf; Manjula Reddy; Thomas Puchalski; Karim Safer; Uma Prabhakar; Klaus Pantel; Ming Qi; Zoran Culig
Journal:  Prostate       Date:  2011-02-14       Impact factor: 4.104

6.  A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.

Authors:  J E Parrillo; C Burch; J H Shelhamer; M M Parker; C Natanson; W Schuette
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

7.  Distinct ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil NADPH oxidase.

Authors:  Glenn E Brown; Mary Q Stewart; Sarah A Bissonnette; Andrew E H Elia; Erik Wilker; Michael B Yaffe
Journal:  J Biol Chem       Date:  2004-04-20       Impact factor: 5.157

8.  Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock.

Authors:  Nazima Pathan; Cheryl A Hemingway; Ash A Alizadeh; Alick C Stephens; Jennifer C Boldrick; Emmanuelle E Oragui; Colm McCabe; Steven B Welch; Adeline Whitney; Peter O'Gara; Simon Nadel; David A Relman; Sian E Harding; Michael Levin
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

Review 9.  The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer.

Authors:  Hae-Young Yong; Min-Soo Koh; Aree Moon
Journal:  Expert Opin Investig Drugs       Date:  2009-12       Impact factor: 6.206

Review 10.  Clinical review: Myocardial depression in sepsis and septic shock.

Authors:  Olivier Court; Aseem Kumar; Joseph E Parrillo; Anand Kumar
Journal:  Crit Care       Date:  2002-09-12       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.